| Filed On | Filing |
|---|---|
| 01 Jun 2021 |
Form 4/A: Evans Daron, CEO Specialty Renal Products
Gave up 698 shares to cover exercise price or tax ($1.88K) |
| 02 May 2019 |
Form 4/A: Lask Alisa, Director
Granted 86,546 Stock Option (right to buy) |
| 20 Dec 2018 |
Form 4/A: Pinto Moshe, Director
Received 47,673 shares as a grant or award |
| 27 Feb 2018 |
Form 4/A: Pinto Moshe, Director
Received 73,864 shares as a grant or award · Granted 40,284 Stock Option (Right to Buy) |
| 15 May 2017 |
Form 4/A: Astor Andrew, Chief Financial Officer
Granted 209,355 Stock Option (right to buy) |
| 05 Jun 2013 |
Form 4/A: Lambda Investors Llc, 10% owner and 4 others
Bought 2,992,884 shares · Received 46,692 shares as a grant or award |
| 05 Nov 2008 |
Form 4/A: Enso Capital Management Llc, 10% owner and 3 others
Sold 29,867 shares ($7.28K) |
| 05 Nov 2008 |
Form 4/A: Enso Capital Management Llc, 10% owner and 3 others
Sold 0 shares (—) |
| 12 Apr 2005 |
Form 4/A: Barta Norman J, Director
Bought 1,100 shares ($3.45K) |
Loading...